MedPath

Culturally Adapted Cognitive Behavior Therapy for Psychosis in Pakistan

Not Applicable
Completed
Conditions
Psychosis
Interventions
Behavioral: Culturally Adapted Cognitive behavior therapy
Registration Number
NCT02202694
Lead Sponsor
Pakistan Institute of Living and Learning
Brief Summary

Aim:

To assess the feasibility of application of culturally-adapted CBT (CaCBTp) for use in Pakistan.

Design:

Randomized Control Trial

Setting:

Psychiatry Departments of General Hospitals in Karachi.

Participants:

A total of 36 patients with a diagnosis of psychotic disorder will be randomized to a psychological intervention or treatment as usual arm.

Intervention:

Culturally Adapted Cognitive Behavioral Therapy (CBT)

Outcome measure:

Positive and Negative syndrome scale (PANSS) Psychotic symptoms Rating Scales (PSYRATS)

Detailed Description

The purpose of the study is to test the feasibility of culturally adaptive CBT for Psychosis in Pakistan

Primary :

-To assess the feasibility of application of culturally-adapted CBT (CaCBTp) for use in Pakistan.

Secondary:

* To assess fidelity of culturally-adapted CBT for psychosis.

* To further modify CaCBTp in accordance with findings of feasibility study

The Participants will be recruited from psychiatric department of different hospitals.They will be randomly divided into two groups; intervention group and treatment-as-usual group. A total of thirtysix participants will be recruited in the feasibility study and divided equally into two arms. This will ensure that, even after loss to follow-up, the investigators will have at least 12 subjects per group for analysis (FDA guidance http://www.fda.gov/cder/guidance/5356fnl.pdf. Randomization will be carried out by the on offsite statistician . This will provide a reliable geographically remote service. For intervention group twelve sessions of CaCBTp will be delivered by trained research clinician for a period of three months. Participants in the treatment as usual (TAU) group will be given details of intervention at the end of the study and interested Participants will be offered CaCBTp.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
36
Inclusion Criteria
  1. Diagnosis of Psychosis established by clinician using ICD10 criteria.
  2. Individuals aged between 18-65.
  3. Should not have learning disability.
  4. Resident of Karachi.
  5. Participant is able to give informed written consent
Exclusion Criteria
  1. Severe illness which may affect capacity or markedly affect their ability to participate in interview, e.g. very thought disordered or distressed by symptoms.
  2. Severe drug or alcohol problem (i.e., those who fulfill the criteria for dependence according to ICD10 RDC).

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
InterventionCulturally Adapted Cognitive behavior therapyCulturally Adapted Cognitive Behavior Therapy
Primary Outcome Measures
NameTimeMethod
Positive and Negative syndrome scale (PANSS)up to 6 months

The PANSS is a structured clinical interview consisting of 30 items designed to assess severity of symptoms over the past week on a 7-point scale.

Secondary Outcome Measures
NameTimeMethod
Psychotic Symptom Rating Scales (PSYRATS)Baseline ,3 months & 6 months

The PSYRATS consists of 17 items that focus on auditory hallucinations and delusions experienced over the past week.

Insight rating scaleBaseline ,3 months & 6 months

Assesses Improvement in insight

Calgary Depression Scale for SchizophreniaBaseline ,3 months & 6 months

This is a nine-item scale developed by Addington et al. to assess depression in schizophrenia.

Short Explanatory Model InterviewBaseline ,3 months & 6 months

used to elicit beliefs of mental illness

Trial Locations

Locations (1)

Dow University of Health Sciences

🇵🇰

Karachi, Sindh, Pakistan

© Copyright 2025. All Rights Reserved by MedPath